{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T01:02:24Z","timestamp":1784854944333,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation of Hubei Province (Joint Fund Project)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05315-3","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:09:07Z","timestamp":1779894547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["P53 loss and BRAF V600E mutation suggest potentially divergent pathways to aggressiveness in high grade differentiated thyroid carcinoma"],"prefix":"10.1007","volume":"17","author":[{"given":"Jiaojiao","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"issue":"1","key":"5315_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","volume":"33","author":"ZW Baloch","year":"2022","unstructured":"Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, LiVolsi VA, Papotti MG, Sobrinho-Sim Es M, Tallini G. others. Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocr Pathol. 2022;33(1):27\u201363.","journal-title":"Endocr Pathol"},{"issue":"1","key":"5315_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.path.2022.09.006","volume":"16","author":"V Cracolici","year":"2023","unstructured":"Cracolici V. No Longer Well-Differentiated: Diagnostic Criteria and Clinical Importance of Poorly Differentiated\/High-Grade Thyroid Carcinoma. Surg Pathol Clin. 2023;16(1):45\u201356.","journal-title":"Surg Pathol Clin"},{"key":"5315_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.humpath.2024.01.002","volume":"144","author":"I Tondi Resta","year":"2024","unstructured":"Tondi Resta I, Gubbiotti MA, Montone KT, Livolsi VA, Baloch ZW. Differentiated high grade thyroid carcinomas: Diagnostic consideration and clinical features. Hum Pathol. 2024;144:53\u201360.","journal-title":"Hum Pathol"},{"issue":"7","key":"5315_CR4","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1111\/his.15157","volume":"84","author":"R Ghossein","year":"2024","unstructured":"Ghossein R, Katabi N, Dogan S, Shaha AR, Tuttle RM, Fagin JA, Ganly I, Xu B. Papillary thyroid carcinoma tall cell subtype (PTC-TC) and high-grade differentiated thyroid carcinoma tall cell phenotype (HGDTC-TC) have different clinical behaviour: a?retrospective study of 1456 patients. Histopathology. 2024;84(7):1130\u20138.","journal-title":"Histopathology"},{"key":"5315_CR5","doi-asserted-by":"crossref","unstructured":"Jung CK, Harahap AS. Diagnostic challenges, prognostic assessment, and treatment strategies in high-grade differentiated thyroid carcinoma. Endocrinol Metab (Seoul, Korea). 2025;40(6):830\u2013850.","DOI":"10.3803\/EnM.2025.2725"},{"key":"5315_CR6","doi-asserted-by":"publisher","first-page":"1517907","DOI":"10.3389\/fendo.2025.1517907","volume":"16","author":"Y Xue","year":"2025","unstructured":"Xue Y, Zhuang Y, Chen S. Dynamic survival outcomes of the tall-cell variant of papillary thyroid carcinoma patients after surgery. Front Endocrinol. 2025;16:1517907.","journal-title":"Front Endocrinol"},{"issue":"8","key":"5315_CR7","first-page":"e66913","volume":"16","author":"S Puvvadi","year":"2024","unstructured":"Puvvadi S, Reddy N, Jundi R, Chang A, Silberstein PT, Hsia B. Demographic and Prognostic Factors of the Columnar Cell Variant of Papillary Thyroid Carcinoma: A National Cancer Database Study. Cureus. 2024;16(8):e66913.","journal-title":"Cureus"},{"key":"5315_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.humpath.2023.04.005","volume":"136","author":"MA Gubbiotti","year":"2023","unstructured":"Gubbiotti MA, Andrianus S, Sakhi R, Zhang Q, Montone K, Jalaly JB, Baloch Z. Does the presence of capsule influence prognosis in poorly differentiated thyroid carcinoma? Hum Pathol. 2023;136:96\u2013104.","journal-title":"Hum Pathol"},{"issue":"2","key":"5315_CR9","doi-asserted-by":"publisher","first-page":"e356","DOI":"10.1002\/cjp2.356","volume":"10","author":"H Gu","year":"2024","unstructured":"Gu H, Wang J, Ran W, Li G, Hu S, Zhao H, Wang X, Wang J. Anaplastic and poorly differentiated thyroid carcinomas: genetic evidence of high-grade transformation from differentiated thyroid carcinoma. J Pathol Clin Res. 2024;10(2):e356.","journal-title":"J Pathol Clin Res"},{"issue":"6","key":"5315_CR10","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.3390\/curroncol31060252","volume":"31","author":"AS Harahap","year":"2024","unstructured":"Harahap AS, Roren RS, Imtiyaz S. A Comprehensive Review and Insights into the New Entity of Differentiated High-Grade Thyroid Carcinoma. Curr Oncol (Toronto Ont). 2024;31(6):3311\u201328.","journal-title":"Curr Oncol (Toronto Ont)"},{"issue":"3","key":"5315_CR11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s12022-023-09778-w","volume":"34","author":"SI Jeong","year":"2023","unstructured":"Jeong SI, Kim W, Yu HW, Choi JY, Ahn CH, Moon JH, Choi SI, Cha W, Jeong W. Park SY and others. Incidence and Clinicopathological Features of Differentiated High-Grade Thyroid Carcinomas: An Institutional Experience. Endocr Pathol. 2023;34(3):287\u201397.","journal-title":"Endocr Pathol"},{"issue":"3","key":"5315_CR12","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1089\/thy.2023.0350","volume":"34","author":"AM Poma","year":"2024","unstructured":"Poma AM, Macerola E, Ghossein RA, Tallini G, Basolo F. Prevalence of Differentiated High-Grade Thyroid Carcinoma Among Well-Differentiated Tumors: A Systematic Review and Meta-Analysis. Thyroid: official J Am Thyroid Association. 2024;34(3):314\u201323.","journal-title":"Thyroid: official J Am Thyroid Association"},{"key":"5315_CR13","doi-asserted-by":"crossref","unstructured":"Asioli S, Erickson LA, Righi A, Jin L, Volante M, Jenkins S, Papotti M, Bussolati G, Lloyd RV. Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression. Modern Pathol. 2010;23(9):1269\u20131278.","DOI":"10.1038\/modpathol.2010.117"},{"issue":"2","key":"5315_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.23736\/S0031-0808.23.05040-1","volume":"66","author":"V Cirello","year":"2024","unstructured":"Cirello V, Gambale C, Nikitski AV, Masaki C, Roque JO, Colombo C. Poorly differentiated thyroid carcinoma: molecular, clinico-pathological hallmarks and therapeutic perspectives. Panminerva Med. 2024;66(2):155\u201373.","journal-title":"Panminerva Med"},{"issue":"1","key":"5315_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/PAP.0000000000000380","volume":"30","author":"B Xu","year":"2023","unstructured":"Xu B, Ghossein RA. Advances in Thyroid Pathology: High Grade Follicular Cell-derived Thyroid Carcinoma and Anaplastic Thyroid Carcinoma. Adv Anat Pathol. 2023;30(1):3\u201310.","journal-title":"Adv Anat Pathol"},{"issue":"10","key":"5315_CR16","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/cncy.22454","volume":"129","author":"M Dell\u2019Aquila","year":"2021","unstructured":"Dell\u2019Aquila M, Fiorentino V, Martini M, Capodimonti S, Cenci T, Lombardi CP, Raffaelli M, Pontecorvi A, Fadda G. Pantanowitz L and others. How limited molecular testing can also offer diagnostic and prognostic evaluation of thyroid nodules processed with liquid-based cytology: Role of TERT promoter and BRAF V600E mutation analysis. Cancer Cytopathol. 2021;129(10):819\u201329.","journal-title":"Cancer Cytopathol"},{"key":"5315_CR17","doi-asserted-by":"crossref","unstructured":"Jung CK, Bychkov A, Kakudo K. Update from the 2022 World Health Organization classification of thyroid tumors: a standardized diagnostic approach. Endocrinol Metab (Seoul, Korea). 2022;37(5):703\u2013718.","DOI":"10.3803\/EnM.2022.1553"},{"issue":"2","key":"5315_CR18","first-page":"e220293","volume":"30","author":"CC Juhlin","year":"2022","unstructured":"Juhlin CC, Mete O, Baloch ZW. The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading. Endocrine-related Cancer. 2022;30(2):e220293.","journal-title":"Endocrine-related Cancer"},{"issue":"1","key":"5315_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12020-020-02505-z","volume":"72","author":"LB Donaldson","year":"2021","unstructured":"Donaldson LB, Yan F, Morgan PF, Kaczmar JM, Fernandes JK, Nguyen SA, Jester RL, Day TA. Hobnail variant of papillary thyroid carcinoma: a systematic review and meta-analysis. Endocrine. 2021;72(1):27\u201339.","journal-title":"Endocrine"},{"issue":"11","key":"5315_CR20","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.3390\/cancers14112785","volume":"14","author":"A Spyroglou","year":"2022","unstructured":"Spyroglou A, Kostopoulos G, Tseleni S, Toulis K, Bramis K, Mastorakos G, Konstadoulakis M, Vamvakidis K, Alexandraki KI. Hobnail Papillary Thyroid Carcinoma, A Systematic Review and Meta-Analysis. Cancers. 2022;14(11):2785.","journal-title":"Cancers"},{"issue":"6","key":"5315_CR21","first-page":"e86323","volume":"17","author":"FZ Bouayed","year":"2025","unstructured":"Bouayed FZ, Berhili S, El-Masadi M, El Magroud M, BenSghier A, Moukhlissi M, Mezouar L. Exploring the Rare Hobnail Variant of Papillary Thyroid Carcinoma: A Case Report. Cureus. 2025;17(6):e86323.","journal-title":"Cureus"},{"issue":"1","key":"5315_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00428-025-04384-z","volume":"488","author":"MC Riascos","year":"2026","unstructured":"Riascos MC, Agaimy A, Nos\u00e9 V. Unmasking familial follicular cell-derived thyroid neoplasms associated with syndromes: DICER1 and PTEN-hamartoma tumor syndromes. Virchows Archiv: Int J Pathol. 2026;488(1):147\u201357.","journal-title":"Virchows Archiv: Int J Pathol"},{"issue":"22","key":"5315_CR23","doi-asserted-by":"publisher","first-page":"5258","DOI":"10.3390\/jcm10225258","volume":"10","author":"MI Bellini","year":"2021","unstructured":"Bellini MI, Biffoni M, Patrone R, Borcea MC, Costanzo ML, Garritano T, Melcarne R, Menditto R, Metere A. Scorziello C and others. Poorly Differentiated Thyroid Carcinoma: Single Centre Experience and Review of the Literature. J Clin Med. 2021;10(22):5258.","journal-title":"J Clin Med"},{"issue":"2","key":"5315_CR24","doi-asserted-by":"publisher","first-page":"e220021","DOI":"10.1530\/ETJ-22-0021","volume":"11","author":"J Tong","year":"2022","unstructured":"Tong J, Ruan M, Jin Y, Fu H, Cheng L, Luo Q, Liu Z, Lv Z, Chen L. Poorly differentiated thyroid carcinoma: a clinician\u2019s perspective. Eur thyroid J. 2022;11(2):e220021.","journal-title":"Eur thyroid J"},{"issue":"3","key":"5315_CR25","doi-asserted-by":"publisher","first-page":"152678","DOI":"10.1016\/j.prp.2019.152678","volume":"216","author":"S Agarwal","year":"2020","unstructured":"Agarwal S, Sadiq Q, Ortanca I. Hobnail cells in encapsulated papillary thyroid carcinoma: Report of 2 cases with immunohistochemical and molecular findings and literature analysis. Pathol Res Pract. 2020;216(3):152678.","journal-title":"Pathol Res Pract"},{"issue":"Pt 2","key":"5315_CR26","doi-asserted-by":"publisher","first-page":"148957","DOI":"10.1016\/j.ijbiomac.2025.148957","volume":"333","author":"M Taheri","year":"2025","unstructured":"Taheri M, Abdullah SR, Saber AF, Samsami M, Hussen BM. The dual role of cyclin D1: Unraveling its tumor-promoting mechanisms and opportunities for therapeutics. Int J Biol Macromol. 2025;333(Pt 2):148957.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"5315_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.mce.2013.10.001","volume":"382","author":"A Perri","year":"2014","unstructured":"Perri A, Catalano S, Bonofiglio D, Vizza D, Rovito D, Qi H, Aquila S, Panza S, Rizza P. Lanzino M and others. T3 enhances thyroid cancer cell proliferation through TR\u03b21\/Oct-1-mediated cyclin D1 activation. Mol Cell Endocrinol. 2014;382(1):205\u201317.","journal-title":"Mol Cell Endocrinol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05315-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05315-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05315-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:18:13Z","timestamp":1784852293000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05315-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5315"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05315-3","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"23 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Geriatric Hospital Affiliated to Wuhan University of Science and Technology (Approval No. 20260312001), in accordance with the Declaration of Helsinki. Clinical trial number: not applicable. Written informed consent to participate in this study was obtained from all patients.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication of identifying information, clinical images and details in this online open-access case report was obtained from all patients and\/or their legal guardians.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1069"}}